Continuous glucose monitoring: Using cgm to guide insulin therapy virtual trials results

Errors; Glucose; Insulin; Nursing; Stars; Stochastic models; Stochastic systems; Blood glucose level; Continuous glucose monitoring; Continuous glucosemonitoring (CGM); Glycemic control; High-frequency noise; Sampling period; Simple modeling; Virtual patients; Gas burners

Abstract :

[en] Continuous glucose monitoring (CGM) devices can measure blood glucose levels through interstitial measurements almost continuously (1-5min sampling period). However, they are not as accurate as glucose readings from blood measurements. The relation between tissue and blood glucose is dynamic and the sensor signal can degrade over time. In addition, CGM readings contains high frequency noise and can drift between measurements. However, maintaining continuous glucose monitoring has the potential to improve the level of glycemic control achieved and reduce nurse workload. For this purpose, a simple model was designed and tested to see the effect of inherent CGM error on the insulin therapy protocol, STAR (Stochastic TARgeted). An error model was generated from 9 patients that had one Guardian Real-Time CGM device (Medtronic Minimed, Northridge, CA, USA) inserted into their abdomen as part of an observation trial assesing the accuracy of CGM measurements compared to a blood gas analyser and glucometer readings. A resulting error model was then used to simulate the outcomes if the STAR protocol was guided by CGM values on 183 virtual patients. CGM alarms for hyper- and hypo-glycaemic region were included to improve patient safety acting as 'guardrails'. The STAR CGM protocol gave good performance and reduced workload by ∼50%, reducing the number of measurements per day per patient from 13 to 7. The number of hypoglycaemic events increased compared to the current STAR from 0.03% <2.2mmol/L to 0.32%. However, in comparison to other published protocols it is still a very low level of hypoglycaemia and less than clinically acceptable value of 5% <4.0mmol/L. More importantly this study shows great promise for the future of CGM and their use in clinic. With the a newer generation of sensors, specifically designed for the ICU, promising less noise and drift suggesting that a reduced nurse workload without compromising safety or performance is with in reach.? © 2015, IFAC (International Federation of Automatic Control) Hosting by Elsevier Ltd. All rights reserved.

Disciplines :

Laboratory medicine & medical technology
Engineering, computing & technology: Multidisciplinary, general & others

Author, co-author :

Mombaerts, L.; GIGA-Cardiovascular Sciences, University of Liege, Belgium

Thomas, Felicity Louise ; Université de Liège - ULiège > Doct. sc. ingé. & techno. (électr., électro. & inf- paysage)

Signal, M.; Department of Mechanical Engineering, University of Canterbury, Christchurch, New Zealand

Desaive, Thomas ; Université de Liège > Département d'astrophys., géophysique et océanographie (AGO) > Thermodynamique des phénomènes irréversibles

Chase, J. G.; Department of Mechanical Engineering, University of Canterbury, Christchurch, New Zealand

Simanski, O.

Schauer, T.

Misgeld, B.

Language :

English

Title :

Continuous glucose monitoring: Using cgm to guide insulin therapy virtual trials results

Publication date :

2015

Event name :

9th IFAC Symposium on Biological and Medical Systems, BMS 2015

Event date :

31 August 2015 through 2 September 2015

Audience :

International

Journal title :

IFAC-PapersOnLine

ISSN :

2405-8971

eISSN :

2405-8963

Publisher :

IFAC Secretariat

Volume :

Issue :

Pages :

112-117

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 10 May 2016

Statistics

Number of views

67 (7 by ULiège)

Number of downloads

115 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Bagshaw, S. M., Bellomo, R., Jacka, M. J., Egi, M., Hart, G. K., et al. (2009). The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care, 13, 3, R91.
Beardsall, K., Ogilvy-Stuart, A. L., Ahluwalia, J., Thompson, M. & Dunger, D. B. (2005). The continuous glucose monitoring sensor in neonatal intensive care. Archives of Disease in Childhood-Fetal and Neonatal Edition, 90, 4, F307-F310.
Blaha, J., Kopecky, P., Matias, M., Hovorka, R., Kunstyr, J., et al. (2009). Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care, 32, 5, 757-61.
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., et al. (2008). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med, 358, 2, 125-39.
Brunner, R., Kitzberger, R., Miehsler, W., Herkner, H., Madl, C., et al. (2011). Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Critical Care Medicine, 39, 4, 659-664.
Carayon, P. & Gurses, A. (2005). A human factors engineering conceptual framework of nursing workload and patient safety in intensive care units. Intensive Crit Care Nurs, 21, 5, 284-301.
Castle, J. R. & Ward, W. K. (2010). Amperometric glucose sensors: sources of error and potential benefit of redundancy. J Diabetes Sci Technol, 4, 1, 221-5.
Chase, J. G., Suhaimi, F., Penning, S., Preiser, J. C., Le Compte, A. J., et al. (2010). Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomed Eng Online, 9, 84.
Evans, A., Le Compte, A., Tan, C. S., Ward, L., Steel, J., et al. (2012). Stochastic Targeted (STAR) Glycemic Control: Design, Safety, and Performance. Journal of Diabetes Science and Technology, 6, 1, 102-115.
Facchinetti, A., Del Favero, S., Sparacino, G., Castle, J. R., Ward, W. K., et al. (2014). Modeling the glucose sensor error. IEEE Trans Biomed Eng, 61, 3, 620-9.
Finfer, S., Liu, B., Chittock, D. R., Norton, R., Myburgh, J. A., et al. (2012). Hypoglycemia and risk of death in critically ill patients. N Engl J Med, 367, 12, 1108-18.
Fisk, L., Lecompte, A., Penning, S., Desaive, T., Shaw, G., et al. (2012). STAR Development and Protocol Comparison. IEEE Trans BiomedEng, 59, 12, 3357-3364.
Goldberg, P. A., Siegel, M. D., Russell, R. R., Sherwin, R. S., Halickman, J. I., et al. (2004). Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther, 6, 3, 339-47.
Harris, D. L., Battin, M. R., Weston, P. J. & Harding, J. E. (2010). Continuous Glucose Monitoring in Newborn Babies at Risk of Hypoglycemia. Journal of Pediatrics, 157, 2, 198-202.
Holzinger, U., Kitzberger, R., Fuhrmann, V., Schenk, P., Kramer, L., et al. Year. ICU-staff education and implementation of an insulin therapy algorithm improve blood glucose control. In: 18th ESICM Annual Congress, 25-28 September 2005 2005 Amsterdam, Netherlands.
Holzinger, U., Warszawska, J., Kitzberger, R., Wewalka, M., Miehsler, W., et al. (2010). Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care, 33, 3, 467-72.
Lin, J., Razak, N. N., Pretty, C. G., Le Compte, A., Docherty, P., et al. (2011). A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients. Comput Methods Programs Biomed, 102(2) 192-205.
Lonergan, T., Compte, A. L., Willacy, M., Chase, J. G., Shaw, G. M., et al. (2006). A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. Diabetes Technol Ther, 8, 4, 449-62.
Lorencio, C., Leal, Y., Bonet, A., Bondia, J., Palerm, C. C., et al. (2012). Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock. Diabetes Technol Ther, 14, 7, 568-75.
Medtronic, I. 2012. Medtronic Sentrino® CGM System Gains CE Mark. System Designed to Improve Glucose Control in Critical Care Patients. http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle Print&ID=1772458.
Moser, E. G., Crew, L. B. & Garg, S. K. (2010). Role of continuous glucose monitoring in diabetes management. Avances en Diabetologia, 26, 2, 73-78.
Plank, J., Blaha, J., Cordingley, J., Wilinska, M. E., Chassin, L. J., et al. (2006). Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care, 29, 2, 271-6.
Preiser, J. C. & Brunkhorst, F. (2008). Tight glucose control and hypoglycemia. Crit Care Med, 36, 4, 1391; author reply 1391-2.
Pretty, C. G., Chase, J. G., Le Compte, A., Shaw, G. M. & Signal, M. (2010). Hypoglycemia Detection in Critical Care Using Continuous Glucose Monitors: An in Silico Proof of Concept Analysis. J Diabetes Sci Technol, 4, 1, 15-24.
Signal, M. 2013. Continuous Glucose Monitoring and Tight Glycaemic Control in Critically Ill Patients Doctor of Philosophy, University of Canterbury
Signal, M., Pretty, C. G., Chase, J. G., Le Compte, A. & Shaw, G. M. (2010). Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost? J Diabetes Sci Technol, 4, 3, 625-35.
Treggiari, M. M., Karir, V., Yanez, N. D., Weiss, N. S., Daniel, S., et al. (2008). Intensive insulin therapy and mortality in critically ill patients. Crit Care, 12, 1, R29.